172 related articles for article (PubMed ID: 32079256)
21. [Study on HPV infection and p53 protein expression in laryngeal carcinoma].
Qin Z; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Dec; 11(12):546-9. PubMed ID: 10323025
[TBL] [Abstract][Full Text] [Related]
22. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinoma.
Xu Y; Liu S; Yi H; Wang J; Dong P; Li X; Yin S
PLoS One; 2014; 9(12):e115914. PubMed ID: 25536405
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
27. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of MDM2 and P16 in laryngeal squamous cell carcinoma].
Li D; Zhang Q; Zhang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):802-5. PubMed ID: 23259295
[TBL] [Abstract][Full Text] [Related]
30. mdm2 oncogene in laryngeal squamous cell carcinoma.
Mastronikolis N; Ragos V; Fotiades P; Papanikolaou V; Kyrodimos E; Chrysovergis A; Mastronikolis S; Tsiambas E
J BUON; 2020; 25(2):594-596. PubMed ID: 32521839
[TBL] [Abstract][Full Text] [Related]
31. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
33. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
Zhao X; Zhang W; Ji W
Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
[TBL] [Abstract][Full Text] [Related]
34. Impact of
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Cancer Genomics Proteomics; 2021; 18(1):53-65. PubMed ID: 33419896
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma.
Morshed K; Korobowicz E; Szymański M; Skomra D; Gołabek W
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):917-20. PubMed ID: 15924277
[TBL] [Abstract][Full Text] [Related]
36. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
39. [A preliminary study on p53 gene expression and infection of human papilloma virus in laryngeal squamous cell carcinoma].
Xie M; Xiao J; Tao Z; Luo J
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):209-11. PubMed ID: 9868114
[TBL] [Abstract][Full Text] [Related]
40. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
